Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Clearside Biomedical

NASDAQ CLSD
$1.25 -0.10 -8.00%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 20 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

87.32M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
58.76M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.78
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
69.85M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
6.84 %

Upcoming events Clearside Biomedical

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Clearside Biomedical

Stock analysis Clearside Biomedical

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-2.50 8.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-5.49 25.38
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-2.32 4.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
1.13 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
160.33 9.54

Price change Clearside Biomedical per year

1.25$ 7.73$
Min Max

Summary analysis Clearside Biomedical

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Clearside Biomedical

Revenue and net income Clearside Biomedical

All parameters

Stock news Clearside Biomedical

All news
9 August 2022 в 00:36

Clearside Biomedical Shares Rise 17% After Non-Dilutive Financing Deal

9 August 2022 в 00:36

Clearside Biomedical Shares Rise 17% After Non-Dilutive Financing Deal

21 December 2021 в 15:40

Clearside Biomedical Reports Encouraging Safety Results for Axitinib

21 December 2021 в 15:40

Clearside Biomedical Reports Encouraging Safety Results for Axitinib

15 December 2021 в 16:35

Wedbush assumes coverage of Clearside Biomedical with outperform stock rating, $9 price target, down from $19

About company Clearside Biomedical

Clearside Biomedical, Inc., a biopharmaceutical company, engages in the developing and delivering treatments that restore and preserve vision for people with serious eye diseases. Its product includes CLS-AX, an axitinib for suprachoroidal injection which is in Phase 1/2a clinical trial. It also develops XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of macular edema associated with uveitis, diabetic macular edema, and macular edema associated with retinal vein occlusion. The company was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
Address:
900 North Point Parkway, Alpharetta, GA, United States, 30005
Company name: Clearside Biomedical
Issuer ticker: CLSD
ISIN: US1850631045
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2016-06-02
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.clearsidebio.com

On which stock exchange are Clearside Biomedical (CLSD) stocks traded?

Clearside Biomedical (CLSD) stocks are traded on NASDAQ.

What is the ticker of Clearside Biomedical stocks (CLSD)?

The stock ticker of Clearside Biomedical’s stocks or in other words, the code is CLSD. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Clearside Biomedical (CLSD) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Clearside Biomedical (CLSD) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Clearside Biomedical (CLSD) stocks traded?

Clearside Biomedical (CLSD) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Clearside Biomedical (CLSD) stocks today?

The current price of Clearside Biomedical stocks on 14.05.2024 is 1.25 dollars. per share.

What is the dynamics of Clearside Biomedical (CLSD) stocks from the beginning of the year?

Clearside Biomedical (CLSD) quotes have increased by -3.1% from the beginning of the year up to 1.25 dollars. per 1 stocks.

How much did Clearside Biomedical (CLSD) stocks increase in мае 2024?

This month Clearside Biomedical (CLSD) quotes have increased by -1.57% to 1.25 dollars. per share.

How much are Clearside Biomedical (CLSD) stocks worth?

Today, on October, 14.05.2024 Clearside Biomedical’s (CLSD) stocks cost 1.25 dollars..

What is the market capitalization of Clearside Biomedical (CLSD)?

Capitalization is the market value of Clearside Biomedical (CLSD) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 14.05.2024, the market capitalization of Clearside Biomedical (CLSD) is estimated at about 87316534 dollars.